Review of NICE Technology Appraisal Guidance No. 92; healozone for the treatment of tooth decay

Proposal to move guidance to the static list

Having re-run the search strategy from the original assessment report the Institute has not found any relevant additions to the evidence base that would have a material effect on the guidance. Consequently we propose that the original guidance become static.

Topics on the static list may be transferred back to the active list for further appraisal if new evidence becomes available that is likely to have a material effect on the last guidance issued.

In order to be completely confident that this is appropriate, we are asking all relevant consultees and commentators, to inform us of any evidence which would suggest that a review would be beneficial. 

Please note all comments received will be published on the Institute's website when a decision has been taken. 

A full list of the organisations we have contacted is available.

17 July 2008